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Endothelial dysfunction and inflammation: What is the link? cause of death in patients with ESRD [3]. Arteriosclero-
Cardiovascular disease, resulting from arteriosclerotic remod- sis is considered to be an inflammatory disease associated
eling of the vasculature, is the main cause of death in end-
with enhanced oxygen radical formation [4, 5]; enhancedstage renal disease (ESRD) patients. Early during the course
oxidative stress is likely to be a major cause for endothe-of arteriosclerosis, endothelial dysfunction can be detected in
various vascular beds, including peripheral forearm arteries, lial dysfunction. It is the aim of this article to highlight the
as well as the coronary circulation. Furthermore, endothelial interplay of inflammation, endothelial dysfunction, and
dysfunction seems to predict the prognosis of cardiovascular
oxidative stress. Particular emphasis is placed on the roledisease. Therefore, the question deserves attention whether
of angiotensin II (AngII) and atherogenic lipoproteins.endothelial dysfunction is simply a marker of cardiovascular
disease, or an active player in the progress of the disease. A
possible link between arteriosclerosis, endothelial dysfunction,
and cardiovascular disease is increased oxidative stress. In- ENDOTHELIAL DYSFUNCTIONflammatory processes involved in the pathogenesis of arterio-
sclerosis enhance vascular O2¯ formation, leading to endothelial Endothelial dysfunction is a sensitive indicator for car-
dysfunction. An activated renin angiotensin system, together diovascular disease [6], predicts its prognosis [7], and is
with oxidized low-density lipoprotein, may play a prominent closely associated with the development of arteriosclero-role for enhanced vascular oxidative stress. In this context, the
sis [8]. The term endothelial dysfunction could, of course,endothelium is not only a target of oxygen radicals, but may
also contribute to O2¯ formation. It is the aim of this article to implicate a “loss of function” of any of the numerous
highlight the interplay of inflammation, endothelial dysfunc- activities of the endothelium. In the context of vascular
tion, and oxidative stress.
diseases, however, endothelial dysfunction usually de-
scribes reduced dilatory capacities, particularly reduced
NO activity. Probably the most important mechanism
Doubtlessly, one of the major achievements in medi-
leading to reduced NO activity is enhanced oxygen radicalcine during the last two decades has been the discovery
formation. Superoxide anion (O2 ) scavenges NO, yieldingthat the vascular endothelium is not simply a semiperme-
peroxynitrite (ONOO), which is rather stable but canable membrane, but instead forms a most active organ
rearrange to form nitrate and the highly reactive OH•with endocrine and paracrine functions [1]. Concerning
[9]. Many studies clearly indicate that endothelial dys-cardiovascular medicine, most relevant functions of the
function is closely correlated with arteriosclerosis, andendothelium are the release of relaxing factors, contrac-
that O2 formation is enhanced in hypercholesterolemiatile factors, and of antiaggregatory substances. Promi-
and arteriosclerosis [10]. Indeed, endothelial dysfunctionnent representatives of relaxing factors are nitric oxide
can be detected (e.g., by means of reduced forearm blood(NO) and prostacycline (PGI2), both of which also have
antiaggregatory properties on platelets. Endothelium- flow, early in the development of arteriosclerosis, and
derived hyperpolarizing factor (EDHF) is another vaso- in patients with hypercholesterolemia) [11]. Importantly,
dilator released from the endothelium. Endothelin-1 endothelial dysfunction occurs in arteries without visible
(ET-1) and thromboxane (TXA2) are the best-character- characteristics of arteriosclerotic lesions such as fatty
ized endothelial contractile factors so far. Endothelial streaks or plaque formation.
function, with its relevance to cardiovascular medicine, In view of the numerous endocrine and paracrine func-
has frequently been reviewed [2]. tions of the endothelium, the question deserves attention
Arteriosclerotic cardiovascular disease is the main whether endothelial dysfunction is simply a sensitive in-
dicator for cardiovascular disease, or whether it is an
active player in its pathophysiology. To shed some lightKey words: atherosclerosis, inflammation, oxidative stress, antioxi-
dants, oxidized LDL. on these questions, the development of arteriosclerosis
shall briefly be summarized. 2003 by the International Society of Nephrology
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PATHOPHYSIOLOGY OF ARTERIOSCLEROSIS
Arteriosclerosis, a generic term for several diseases
in which the arterial wall becomes thickened and loses
elasticity, is not a static condition; rather, it reflects a
continuous development over decades from macroscopi-
cally intact arteries to grossly damaged and ruptured
sclerotic plaques, with different stages being present si-
multaneously within one individual. Important steps
during atherogenesis include enhanced endothelial per-
meability, expression of adhesion molecules, monocyte
adhesion and immigration, foam cell formation, fatty
streaks, smooth muscle cell migration, plaque formation,
and finally plaque rupture and thrombus formation. Ear-
lier concepts on the pathophysiology of arteriosclerosis
were based on the assumption of an initial injury leading
Fig. 1. Endogenous and exogenous factors contributing to vascularto intimal lesions, and subsequent repair mechanisms inflammation, oxidative stress, endothelial dysfunction, and vascular
(“response to injury” hypothesis) [12]. Today we know remodeling, with particular relevance to patients with end stage renal
disease. Abbreviations are: AngII, angiotensin II; OxLDL, oxidizedthat even in macroscopically intact arteries, processes
LDL; LPS, lipopolysaccharide; AGEs, advanced glycation end products;
take place that can be best defined as chronically in- CVC, central venous catheter.
flammatory [4]. Arguments that support the hypothesis
of a chronic inflammation in arteriosclerosis include the
following: Cells found in early atherosclerotic lesions are
nary endothelial dysfunction is a strong predictor fortypically inflammatory cells (monocytes/macrophages
future cardiovascular events in patients with coronaryand T-lymphocytes); early in arteriosclerosis, enhanced
heart disease [7].vascular oxygen radical formation can be detected, as
Thus, there is strong evidence that arteriosclerosis is anwell as enhanced activity of lipoxygenases; arteriosclero-
inflammatory disease, and that endothelial dysfunction issis is associated with enhanced serum levels of inflam-
an early event in this process. How could inflammationmation parameters; the arteriosclerotic artery produces
contribute to endothelial dysfunction, and how could thedifferent hydrolytic enzymes, adhesion molecules, cyto-
endothelium contribute to inflammation?kines, and growth factors, as seen in chronic inflamma-
tion. In addition, large clinical studies clearly show a
strong correlation between markers of inflammation and PATHOPHYSIOLOGY OF INFLAMMATION
clinical outcome in patients with coronary heart disease. AND CONSEQUENCES OF ENHANCED
In particular, high sensitive C-reactive protein (hs-CRP) OXIDATIVE STRESS FOR VASCULAR
has been identified as a predictor for cardiovascular AND RENAL FUNCTION
events in patients with and without known coronary Certainly, many different factors may contribute to
heart disease [13, 14]. the state of inflammation in the vasculature, as summa-
As mentioned above, at very early stages of arterio- rized in Figure 1. For patients with ESRD, it makes
sclerosis (characterized by enhanced endothelial perme- sense to distinguish between endogenous and exogenous
ability, expression of adhesion molecules, monocyte ad- factors, because the dialysis treatment, in addition to
hesion, and immigration), endothelial dysfunction can uremia, may be a source for continuous exposure to pro-
be detected. For example, in one study, the intima-media inflammatory stimuli. What these different factors have
thickness and plaque formation of the common carotid in common is that they all—albeit by different mecha-
artery of 34 men with arteriosclerosis was correlated with nisms—enhance oxidative stress. Endothelial dysfunc-
flow mediated dilation (FMD) of the brachial artery. A tion through scavenging of NO by O2 is one important
significant negative correlation of FMD with the intima- consequence of enhanced oxidative stress, as outlined
media thickness of the common carotid artery was found, above. In various vascular or renal diseases, enhanced
supporting the concept that endothelial dysfunction is formation of reactive oxygen species is considered to be
significantly related to atherogenesis [8]. In another pathogenic (e.g., in atherosclerosis, glomerular diseases,
study, a close relation between coronary artery endothe- renal failure, pyelonephritis, or aminoglycoside ne-
lium-dependent vasomotor responses to acetylcholine phropathy) [15, 16]. Furthermore, oxidative stress impor-
and FMD in the brachial artery was found [6]. The rele- tantly influences vascular cell cycle decisions; induction
vance of endothelial dysfunction for the prognosis of of apoptosis [17, 18], as well as induction of cell prolifera-
tion [19], has been described.patients was shown in a study of the Mayo Clinic: coro-
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The scope of this article would be disrupted if all the AngII-induced stimulation of O2 formation could be
inhibited by diphenylene iodinium, suggesting that O2influences listed in Figure 1 which contribute to inflam-
was produced by membrane-bound NAD(P)H oxidasesmation and oxidative stress should be discussed in detail.
[26]. In the mean time, it has been shown that AngIIInstead, we will focus on two factors, AngII and oxidized
also induces O2 formation in endothelial cells and non-low density lipoprotein (OxLDL), for two reasons: First,
vascular tissue [28]. In numerous studies, it has beenAngII and OxLDL are well characterized as potentially
demonstrated that AngII stimulates vascular NAD(P)Hendothelium-damaging agents, and, second, we possess
oxidase-dependent O2 formation via the AT1-receptor.pharmacologic tools to interfere with their activity.
The NAD(P)H oxidase consists of four major subunits:
a plasma membrane spanning cytochrome b558 (com-
ANGII AND OXIDIZED LDL posed of the large subunit gp91phox and the small sub-
unit p22phox), and 2 cytosolic components, p47phox andAccumulation of OxLDL in atherosclerotic plaques is
p67phox [29]. In smooth muscle cells, the NADPH sub-a well-known event in the development of atherosclero-
units p22phox, p47phox, and eventually p67phox, aresis [20]. Only recently did it become apparent that ath-
involved in O2 formation [29]. In endothelial cells,erosclerotic arteries (human atherectomy preparations
mRNAs for gp91phox, p22phox, p47phox, and p67phoxand arteries of hypercholesterolemic monkeys) show en-
have been detected, and the gp91phox [30] and p22phoxrichment with AngII, co-localizing with resident macro-
[19] subunits seem to be of particular importance forphages [21]. Thus, AngII accumulates in the same vascu-
O2 formation in endothelial cells.lar region as OxLDL. Not only do AngII and OxLDL
co-localize in atherosclerotic plaques, there is strong ex-
perimental evidence that these agents interact with each SPECIFIC EFFECTS OF ANGII-INDUCED
OXYGEN RADICAL FORMATIONother, with relevance for vascular biology and athero-
sclerosis. The particular importance of AngII-induced oxidative
stress for vascular biology has been investigated in the
context of vasomotor tone and of cell cycle regulationEVIDENCE FOR A POTENTIAL INTERACTION
(e.g., enhanced O2 formation resulted in impairment ofBETWEEN ANGII AND OXIDIZED LDL
endothelium-dependent dilations) [31], which could be
Clinical studies suggest that ACE-inhibitors are of par- prevented by liposome-encapsulated superoxide dismu-
ticular benefit for endothelial function in hypercholester- tase. Indirect evidence that AngII-induced O2 formation
olemic patients with high LDL levels [22, 23]. Further- takes place in vivo in humans was provided by a study
more, several studies have shown that the expression of using the forearm plethysmography method, which al-
the OxLDL receptor LOX-1, and of the AT1 receptor, lows direct measurement of AngII-induced vasomotor
is stimulated by the respective other receptor agonist actions. Constrictor actions of AngII in the human fore-
[24, 25]. In cultured smooth muscle cells, LDL induced arm were enhanced during NO inhibition and were at-
tenuated during vitamin C infusion, suggesting AngII-expression of the AT1 receptor [24]. Thus, LDL may
associated stimulation of endothelial NO and of oxygensensitize the vascular tissue to AngII. On the other hand,
radicals, respectively [32].expression of the OxLDL receptor LOX-1 and uptake
The impact of AngII on cell cycle decisions via activa-of OxLDL in human umbilical vein endothelial cells
tion of NAD(P)H-dependent oxidases has been demon-(HUVEC) is increased by AngII [25]. Together, these
strated in vascular and nonvascular tissue, and may bestudies imply that AngII and OxLDL amplify the effect
of particular importance for cellular turnover in arterio-of the respective other agonist. But how could AngII
sclerosis. For example, AngII causes vascular smooth mus-and OxLDL contribute to arteriosclerosis, inflammation,
cle cell hypertrophy, and inhibition of p22phox mRNAand endothelial dysfunction?
expression in vascular smooth muscle cells results in a
significant inhibition of AngII-stimulated NADH(P)H-
dependent superoxide production, subsequent hydrogenEXPERIMENTAL EVIDENCE FOR PRO-
peroxide production, and H3-leucine incorporation [33].INFLAMMATORY AND PRO-OXIDATIVE
Thus, AngII-induced O2 formation has important con-EFFECTS OF ANGII
sequences for the NO metabolism and for cell cycle deci-Recently, it has become apparent that AngII is a po-
sions, potentially affecting the course of arteriosclerosis.tent stimulator of vascular oxygen radical production,
thereby contributing to endothelial dysfunction and in-
OXIDATIVE STRESS INDUCED BY OXLDLflammation [26, 27]. Cell culture studies with rat smooth
AND FUNCTIONAL CONSEQUENCESmuscle cell preparations provided first experimental evi-
dence for stimulation of O2 formation by AngII [26]. In Animal studies with cholesterol-fed rabbits provided
first the indirect evidence for a role of LDL in the induc-experiments with rat smooth muscle cell membranes,
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